FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

2023 Annual Long-Range Planning Meeting
December 21, 2022

The Division of Medical Quality Assurance has announced the 2023 Annual Long-Range Planning meeting. Click here for more information. Continue reading


Governor DeSantis declares State of Emergency for Subtropical Storm Nicole
November 7, 2022

On Monday, November 7, 2022, Governor Ron DeSantis declared a State of Emergency to prepare for Subtropical Storm Nicole. Continue reading